SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?


To: Bill Tomko who wrote (463)12/28/1997 11:18:00 AM
From: Brander  Read Replies (1) | Respond to of 834
 
Bill, there is no new information that I know of. There did seem to be some confusion on the thread concerning the history of Novastans, esp how TXB acquired it. That is why I posted the 10-K. Also, what I was refering to in my last post to Mr Wexler is that some of TXB's news releases do seem, to the uninformed investor, to suggest that TXB developed the drug. I am still waiting to hear if Mr Wexler really has any evidence that TXB fudged the results of the important clincial trials. That is a very serious charge. I have read some of the scientific literature on Novastan, and, to me, the drug looks very promising. I have also read some of the results from TXB's studies of Navastan. The work was done by reputable scientists, and the results seem very sound, to me. I am still long on this one. It is a speculative company, but, IMO, a very good bet for a spec. In the short term, and perhaps long term, their future depends on FDA approval, which is expected 1st or 2nd Q 1998, so we don't have that long to wait. All of the indicators that I have seen, and whisper talk, suggest Novastan will be approved. I continue to invite Mr Wexler to provide evidence otherwise.

Brad



To: Bill Tomko who wrote (463)12/28/1997 12:04:00 PM
From: Dauntless  Read Replies (3) | Respond to of 834
 
Bill, save your breath

The more you prove this guy wrong with facts and/or logic, the more he will resort to ranting & raving. Soon he will begin reposting old messages.

You have challenged him on several of his claims - see if comes back with anything reasonable.

Go with what you know - this guy has proven himself to have an agenda and he will not be interrupted by the truth.



To: Bill Tomko who wrote (463)12/29/1997 5:51:00 AM
From: Bill Wexler  Read Replies (1) | Respond to of 834
 
<<I don't see the issue re a commision on research funds.>>

Then you should be able to produce another example of a legitimate biotech firm which pays its stock touts a portion of research funds.